Financial Highlights
Revenue and profitability: Revenue of $590,236, down 22.8% YoY and up 1.9% QoQ; Gross profit $92,847, gross margin 15.73%; Operating income $(965,889), margin -1.64%; EBITDA $(965,889), margin -163.6%; Net income $(964,494), EPS $(0.029). Cost structure: COGS $497,389; R&D $8,617; G&A $1,050,119; SG&A consolidated at $1,050,119; total operating expenses $1,058,736. Cash flow and liquidity: Net cash used in operating activities $(593,031); ending cash $(393,396); free cash flow $(593,031). Balance sheet: Total assets $4,150,110; current assets $4,150,110; total current liabilities $253,775; cash and equivalents $393,396; total stockholders’ equity $(3,896,335) despite a cash cushion; retained earnings $(21,707,032); net working capital elevated by accounts receivable $1,950,684 and inventory $1,767,624. Liquidity ratios: current ratio 16.35x; quick ratio 9.39x; cash ratio 1.55x. Turnover and efficiency: DSO 297.4 days; DIO 319.8 days; DPO 39.1 days; CCC 578.1 days. Valuation snapshot: price-to-sales 45.45x; price-to-book 6.88x; enterprise value multiple negative; earnings multiple negative (P/E); price-to-operating cash flows negative. YoY and QoQ revenue and profit trends reflect a scale-up phase with cost discipline required to achieve profitability.
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Revenue |
590.24K |
-22.76% |
1.90% |
| Gross Profit |
92.85K |
-23.38% |
441.16% |
| Operating Income |
-965.89K |
-122.56% |
-31.63% |
| Net Income |
-964.49K |
-124.97% |
-32.29% |
| EPS |
-0.03 |
-124.81% |
-31.82% |